2018-2023 Global Budesonide Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Budesonide market for 2018-2023.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Statistic for budesonide in this report includes three product types: nasal spray, inhaler and pill&rectal forms.
North America is the largest consumer in the past years. North America occupied more than 40% consumption market share in 2015. Europe is the second largest region around the world, it occupied about 34% consumption market share in 2015.
There are three type of budesonide product in the market: nasal spray,inhaler and pill&rectal forms. Inhaler has the largest output due to the large asthma treatment market.
AstraZeneca is the leading company in the budesonide market. Its revenue from budesonide is 1.3 billion USD in 2015, occupied more than half of global budesonide market.
Over the next five years, LPI(LP Information) projects that Budesonide will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Budesonide market for 2018-2023.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Statistic for budesonide in this report includes three product types: nasal spray, inhaler and pill&rectal forms.
North America is the largest consumer in the past years. North America occupied more than 40% consumption market share in 2015. Europe is the second largest region around the world, it occupied about 34% consumption market share in 2015.
There are three type of budesonide product in the market: nasal spray,inhaler and pill&rectal forms. Inhaler has the largest output due to the large asthma treatment market.
AstraZeneca is the leading company in the budesonide market. Its revenue from budesonide is 1.3 billion USD in 2015, occupied more than half of global budesonide market.
Over the next five years, LPI(LP Information) projects that Budesonide will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Nasal Spray
- Inhaler
- Pill&Rectal Forms
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Cosmo Pharmaceuticals
- Teva
- Mylan
- Sandoz
- Dr. Falk Pharma
- Chiesi Farmaceutici S.p.A
- Orion Corporation
- Cipla
- Synmosa Biopharma Corporation
- Lunan Better Pharmaceutical
- Shanghai Sine Promod Pharmaceutical
Research objectives
- To study and analyze the global Budesonide consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Budesonide market by identifying its various subsegments.
- Focuses on the key global Budesonide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Budesonide with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Budesonide submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Budesonide Consumption 2013-2023
2.1.2 Budesonide Consumption CAGR by Region
2.2 Budesonide Segment by Type
2.2.1 Nasal Spray
2.2.2 Inhaler
2.2.3 Pill&Rectal Forms
2.3 Budesonide Consumption by Type
2.3.1 Global Budesonide Consumption Market Share by Type (2013-2018)
2.3.2 Global Budesonide Revenue and Market Share by Type (2013-2018)
2.3.3 Global Budesonide Sale Price by Type (2013-2018)
2.4 Budesonide Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.5 Budesonide Consumption by Application
2.5.1 Global Budesonide Consumption Market Share by Application (2013-2018)
2.5.2 Global Budesonide Value and Market Share by Application (2013-2018)
2.5.3 Global Budesonide Sale Price by Application (2013-2018)
3 GLOBAL BUDESONIDE BY PLAYERS
3.1 Global Budesonide Sales Market Share by Players
3.1.1 Global Budesonide Sales by Players (2016-2018)
3.1.2 Global Budesonide Sales Market Share by Players (2016-2018)
3.2 Global Budesonide Revenue Market Share by Players
3.2.1 Global Budesonide Revenue by Players (2016-2018)
3.2.2 Global Budesonide Revenue Market Share by Players (2016-2018)
3.3 Global Budesonide Sale Price by Players
3.4 Global Budesonide Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Budesonide Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Budesonide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 BUDESONIDE BY REGIONS
4.1 Budesonide by Regions
4.1.1 Global Budesonide Consumption by Regions
4.1.2 Global Budesonide Value by Regions
4.2 Americas Budesonide Consumption Growth
4.3 APAC Budesonide Consumption Growth
4.4 Europe Budesonide Consumption Growth
4.5 Middle East & Africa Budesonide Consumption Growth
5 AMERICAS
5.1 Americas Budesonide Consumption by Countries
5.1.1 Americas Budesonide Consumption by Countries (2013-2018)
5.1.2 Americas Budesonide Value by Countries (2013-2018)
5.2 Americas Budesonide Consumption by Type
5.3 Americas Budesonide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Budesonide Consumption by Countries
6.1.1 APAC Budesonide Consumption by Countries (2013-2018)
6.1.2 APAC Budesonide Value by Countries (2013-2018)
6.2 APAC Budesonide Consumption by Type
6.3 APAC Budesonide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Budesonide by Countries
7.1.1 Europe Budesonide Consumption by Countries (2013-2018)
7.1.2 Europe Budesonide Value by Countries (2013-2018)
7.2 Europe Budesonide Consumption by Type
7.3 Europe Budesonide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Budesonide by Countries
8.1.1 Middle East & Africa Budesonide Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Budesonide Value by Countries (2013-2018)
8.2 Middle East & Africa Budesonide Consumption by Type
8.3 Middle East & Africa Budesonide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Budesonide Distributors
10.3 Budesonide Customer
11 GLOBAL BUDESONIDE MARKET FORECAST
11.1 Global Budesonide Consumption Forecast (2018-2023)
11.2 Global Budesonide Forecast by Regions
11.2.1 Global Budesonide Forecast by Regions (2018-2023)
11.2.2 Global Budesonide Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Budesonide Forecast by Type
11.8 Global Budesonide Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AstraZeneca
12.1.1 Company Details
12.1.2 Budesonide Product Offered
12.1.3 AstraZeneca Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 AstraZeneca News
12.2 Cosmo Pharmaceuticals
12.2.1 Company Details
12.2.2 Budesonide Product Offered
12.2.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Cosmo Pharmaceuticals News
12.3 Teva
12.3.1 Company Details
12.3.2 Budesonide Product Offered
12.3.3 Teva Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Teva News
12.4 Mylan
12.4.1 Company Details
12.4.2 Budesonide Product Offered
12.4.3 Mylan Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Sandoz
12.5.1 Company Details
12.5.2 Budesonide Product Offered
12.5.3 Sandoz Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Sandoz News
12.6 Dr. Falk Pharma
12.6.1 Company Details
12.6.2 Budesonide Product Offered
12.6.3 Dr. Falk Pharma Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Dr. Falk Pharma News
12.7 Chiesi Farmaceutici S.p.A
12.7.1 Company Details
12.7.2 Budesonide Product Offered
12.7.3 Chiesi Farmaceutici S.p.A Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Chiesi Farmaceutici S.p.A News
12.8 Orion Corporation
12.8.1 Company Details
12.8.2 Budesonide Product Offered
12.8.3 Orion Corporation Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Orion Corporation News
12.9 Cipla
12.9.1 Company Details
12.9.2 Budesonide Product Offered
12.9.3 Cipla Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Cipla News
12.10 Synmosa Biopharma Corporation
12.10.1 Company Details
12.10.2 Budesonide Product Offered
12.10.3 Synmosa Biopharma Corporation Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Synmosa Biopharma Corporation News
12.11 Lunan Better Pharmaceutical
12.12 Shanghai Sine Promod Pharmaceutical
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Budesonide Consumption 2013-2023
2.1.2 Budesonide Consumption CAGR by Region
2.2 Budesonide Segment by Type
2.2.1 Nasal Spray
2.2.2 Inhaler
2.2.3 Pill&Rectal Forms
2.3 Budesonide Consumption by Type
2.3.1 Global Budesonide Consumption Market Share by Type (2013-2018)
2.3.2 Global Budesonide Revenue and Market Share by Type (2013-2018)
2.3.3 Global Budesonide Sale Price by Type (2013-2018)
2.4 Budesonide Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.5 Budesonide Consumption by Application
2.5.1 Global Budesonide Consumption Market Share by Application (2013-2018)
2.5.2 Global Budesonide Value and Market Share by Application (2013-2018)
2.5.3 Global Budesonide Sale Price by Application (2013-2018)
3 GLOBAL BUDESONIDE BY PLAYERS
3.1 Global Budesonide Sales Market Share by Players
3.1.1 Global Budesonide Sales by Players (2016-2018)
3.1.2 Global Budesonide Sales Market Share by Players (2016-2018)
3.2 Global Budesonide Revenue Market Share by Players
3.2.1 Global Budesonide Revenue by Players (2016-2018)
3.2.2 Global Budesonide Revenue Market Share by Players (2016-2018)
3.3 Global Budesonide Sale Price by Players
3.4 Global Budesonide Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Budesonide Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Budesonide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 BUDESONIDE BY REGIONS
4.1 Budesonide by Regions
4.1.1 Global Budesonide Consumption by Regions
4.1.2 Global Budesonide Value by Regions
4.2 Americas Budesonide Consumption Growth
4.3 APAC Budesonide Consumption Growth
4.4 Europe Budesonide Consumption Growth
4.5 Middle East & Africa Budesonide Consumption Growth
5 AMERICAS
5.1 Americas Budesonide Consumption by Countries
5.1.1 Americas Budesonide Consumption by Countries (2013-2018)
5.1.2 Americas Budesonide Value by Countries (2013-2018)
5.2 Americas Budesonide Consumption by Type
5.3 Americas Budesonide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Budesonide Consumption by Countries
6.1.1 APAC Budesonide Consumption by Countries (2013-2018)
6.1.2 APAC Budesonide Value by Countries (2013-2018)
6.2 APAC Budesonide Consumption by Type
6.3 APAC Budesonide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Budesonide by Countries
7.1.1 Europe Budesonide Consumption by Countries (2013-2018)
7.1.2 Europe Budesonide Value by Countries (2013-2018)
7.2 Europe Budesonide Consumption by Type
7.3 Europe Budesonide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Budesonide by Countries
8.1.1 Middle East & Africa Budesonide Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Budesonide Value by Countries (2013-2018)
8.2 Middle East & Africa Budesonide Consumption by Type
8.3 Middle East & Africa Budesonide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Budesonide Distributors
10.3 Budesonide Customer
11 GLOBAL BUDESONIDE MARKET FORECAST
11.1 Global Budesonide Consumption Forecast (2018-2023)
11.2 Global Budesonide Forecast by Regions
11.2.1 Global Budesonide Forecast by Regions (2018-2023)
11.2.2 Global Budesonide Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Budesonide Forecast by Type
11.8 Global Budesonide Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AstraZeneca
12.1.1 Company Details
12.1.2 Budesonide Product Offered
12.1.3 AstraZeneca Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 AstraZeneca News
12.2 Cosmo Pharmaceuticals
12.2.1 Company Details
12.2.2 Budesonide Product Offered
12.2.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Cosmo Pharmaceuticals News
12.3 Teva
12.3.1 Company Details
12.3.2 Budesonide Product Offered
12.3.3 Teva Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Teva News
12.4 Mylan
12.4.1 Company Details
12.4.2 Budesonide Product Offered
12.4.3 Mylan Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Sandoz
12.5.1 Company Details
12.5.2 Budesonide Product Offered
12.5.3 Sandoz Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Sandoz News
12.6 Dr. Falk Pharma
12.6.1 Company Details
12.6.2 Budesonide Product Offered
12.6.3 Dr. Falk Pharma Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Dr. Falk Pharma News
12.7 Chiesi Farmaceutici S.p.A
12.7.1 Company Details
12.7.2 Budesonide Product Offered
12.7.3 Chiesi Farmaceutici S.p.A Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Chiesi Farmaceutici S.p.A News
12.8 Orion Corporation
12.8.1 Company Details
12.8.2 Budesonide Product Offered
12.8.3 Orion Corporation Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Orion Corporation News
12.9 Cipla
12.9.1 Company Details
12.9.2 Budesonide Product Offered
12.9.3 Cipla Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Cipla News
12.10 Synmosa Biopharma Corporation
12.10.1 Company Details
12.10.2 Budesonide Product Offered
12.10.3 Synmosa Biopharma Corporation Budesonide Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Synmosa Biopharma Corporation News
12.11 Lunan Better Pharmaceutical
12.12 Shanghai Sine Promod Pharmaceutical
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Budesonide
Table Product Specifications of Budesonide
Figure Budesonide Report Years Considered
Figure Market Research Methodology
Figure Global Budesonide Consumption Growth R
Figure Picture of Budesonide
Table Product Specifications of Budesonide
Figure Budesonide Report Years Considered
Figure Market Research Methodology
Figure Global Budesonide Consumption Growth R
